Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

KΓΆrber Signs Strategic Agreement with Chinese Domestic Cell & Gene Therapy Leader to Set Up Smart Factory

KΓΆrber and Immunotech Biopharm will implement Werum PAS-X MES in a greenfield cell & gene site in Beijing. This step is an important milestone to start Immunotech’s digital journey towards intelligent manufacturing.

The signing ceremony (from left): Jerry Zheng, General Manager China Hub, Körber Business Area Pharma, and Dr. Wang Yu, CEO, Immunotech Biopharm
The signing ceremony (from left): Jerry Zheng, General Manager China Hub, KΓΆrber Business Area Pharma, and Dr. Wang Yu, CEO, Immunotech Biopharm

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

As the China domestic leader in cell & gene therapy, Immunotech regards digitization and intelligent manufacturing as one of the company’s core strategies. By introducing KΓΆrber’s Manufacturing Execution System (MES) Werum PAS-X in the greenfield site in Beijing, Immunotech will build a new smart factory that takes into account safety and efficiency, while enabling interconnection and data transfer during the entire production process. In this way, the company can accelerate the strategic process of digitization and intelligence, and provide more high-quality products and services to the market.

β€œWe are very pleased to reach a comprehensive cooperation with KΓΆrber,” says Dr. Wang Yu, chief executive officer (CEO) of Immunotech Biopharm Ltd. β€œAs the market leader, Werum PAS-X MES has unique advantages, which offers us innovative concepts and industry best practices. PAS-X combines software, content and services, and ensures fast deployment. I am looking forward to our joint cooperation, laying a solid foundation for Immunotech to accelerate product commercialization as well as to provide strong technical support to achieve our ultimate goal of curing patients.”

Jerry Zheng, general manager China Hub of KΓΆrber Business Area Pharma, adds: β€œAgainst the backdrop of Industry 4.0, the strategic plan β€˜Made in China 2025’ and the integration of digitization and intelligence in various industries across China, leveraging technology to assist the pharmaceutical industry is the trend of the future. Our PAS-X software solution has always been focusing on the factory and supply chain, while taking into account the specific requirements of the regulatory agencies and the industry itself. MES is an important entry point and breakthrough to drive intelligent manufacturing, and it is an important vehicle for the digital transformation of pharmaceutical companies.”

Fill out the form below to request more information about KΓΆrber Signs Strategic Agreement with Chinese Domestic Cell & Gene Therapy Leader to Set Up Smart Factory
Coding, Marking, and Labeling Innovations Report
Explore our editor-curated report featuring cutting-edge coding, labeling, and RFID innovations from PACK EXPO 2024. Discover high-speed digital printing, sustainable label materials, automated labeling systems, and advanced traceability solutions that are transforming packaging operations across industries.
Access Report
Coding, Marking, and Labeling Innovations Report
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce